Éva Barabás

791 total citations
49 papers, 634 citations indexed

About

Éva Barabás is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Éva Barabás has authored 49 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Hematology. Recurrent topics in Éva Barabás's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Chemical Synthesis and Analysis (6 papers) and HIV Research and Treatment (5 papers). Éva Barabás is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Chemical Synthesis and Analysis (6 papers) and HIV Research and Treatment (5 papers). Éva Barabás collaborates with scholars based in United States, Hungary and Italy. Éva Barabás's co-authors include D Bagdy, S. Bajusz, E. Széll, Attila Juhász, László Gráf, Staffan Magnusson, Gyula Horváth, Torben E. Petersen, Elemér K. Zsigmond and L. Gráf and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Éva Barabás

45 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éva Barabás United States 12 248 216 160 100 89 49 634
Richard Faint United Kingdom 13 193 0.8× 181 0.8× 84 0.5× 87 0.9× 175 2.0× 17 556
J.R. Bertino United States 16 462 1.9× 105 0.5× 221 1.4× 69 0.7× 52 0.6× 28 925
James Lawrence United States 13 393 1.6× 72 0.3× 66 0.4× 21 0.2× 91 1.0× 23 1.0k
Edward D. Gilby United Kingdom 17 247 1.0× 97 0.4× 328 2.0× 31 0.3× 36 0.4× 31 802
Nahed K. Ahmed United States 13 272 1.1× 60 0.3× 87 0.5× 29 0.3× 66 0.7× 30 533
Larry W. Brox Canada 21 865 3.5× 113 0.5× 173 1.1× 50 0.5× 87 1.0× 42 1.2k
E. Cama United States 9 206 0.8× 80 0.4× 40 0.3× 74 0.7× 36 0.4× 9 575
Nancy S. Nicholson United States 18 181 0.7× 402 1.9× 46 0.3× 113 1.1× 31 0.3× 34 905
Yuichiro Yabe Japan 16 264 1.1× 73 0.3× 69 0.4× 117 1.2× 15 0.2× 54 684
A C Cox United States 13 236 1.0× 240 1.1× 31 0.2× 25 0.3× 44 0.5× 20 619

Countries citing papers authored by Éva Barabás

Since Specialization
Citations

This map shows the geographic impact of Éva Barabás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éva Barabás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éva Barabás more than expected).

Fields of papers citing papers by Éva Barabás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éva Barabás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éva Barabás. The network helps show where Éva Barabás may publish in the future.

Co-authorship network of co-authors of Éva Barabás

This figure shows the co-authorship network connecting the top 25 collaborators of Éva Barabás. A scholar is included among the top collaborators of Éva Barabás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éva Barabás. Éva Barabás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagy, Anna, et al.. (2022). West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019. PLoS ONE. 17(4). e0266840–e0266840. 11 indexed citations
2.
Kis, Zoltán, Éva Barabás, Anna Nagy, et al.. (2020). New geographical area on the map of Crimean-Congo hemorrhagic fever virus: First serological evidence in the Hungarian population. Ticks and Tick-borne Diseases. 12(1). 101555–101555. 16 indexed citations
3.
Nagy, Anna, et al.. (2019). West Nile Virus Seroprevalence Among Blood Donors in Hungary. Vector-Borne and Zoonotic Diseases. 19(11). 844–850. 7 indexed citations
4.
Juhász, Gabriella, et al.. (2016). Phylogenetic analysis of a transfusion-transmitted hepatitis A outbreak. Virus Genes. 53(1). 15–20. 8 indexed citations
5.
Barabás, Éva, et al.. (2001). Comparison of the quantitative competitive and semiquantitative RT-PCR methods for the determination of interferon-gamma mRNA levels in AIDS-free HIV-infected individuals. Brazilian Journal of Medical and Biological Research. 34(10). 1271–1275. 8 indexed citations
6.
Bajusz, S., et al.. (1998). Peptidyl β-homo-aspartals: Specific inhibitors of interleukin-1β converting enzyme and its homologues (caspases). Bioorganic & Medicinal Chemistry Letters. 8(12). 1477–1482. 9 indexed citations
7.
Csiszár, Anna, et al.. (1998). Studies on the antibodies to human herpesvirus type 6 among Hungarian patients with asymptomatic HIV infection. Pathology & Oncology Research. 4(1). 56–61. 1 indexed citations
8.
Nagy, K., et al.. (1996). Determination of HIV-1 subtypes in Hungary by synthetic peptides representing the V3 loop ofenv. Pathology & Oncology Research. 2(4). 268–271. 5 indexed citations
9.
Bajusz, S., et al.. (1995). Active site-directed thrombin inhibitors: α-hydroxyacylprolyl-arginals. New orally active stable analogs of d-Phe-Pro-Arg-H. Bioorganic & Medicinal Chemistry. 3(8). 1079–1089. 9 indexed citations
10.
Barabás, Éva, E. Széll, & S. Bajusz. (1993). Screening for fibrinolysis inhibitory effect of synthetic thrombin inhibitors. Blood Coagulation & Fibrinolysis. 4(2). 243–248. 16 indexed citations
11.
Bajusz, S., E. Széll, D Bagdy, et al.. (1990). Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H. Journal of Medicinal Chemistry. 33(6). 1729–1735. 141 indexed citations
12.
Zsigmond, Elemér K., et al.. (1990). Protection from stress of tracheal intubation with midazolam-sufentanil neuroleptanalgesia.. PubMed. 28(1). 2–6. 2 indexed citations
13.
Zsigmond, Elemér K., et al.. (1988). Esmolol attenuates tachycardia caused by tracheal intubation: a double-blind study.. PubMed. 26(5). 225–31. 8 indexed citations
14.
Zsigmond, Elemér K., et al.. (1988). Endocrine and Hemodynamic Effects of Antagonism of Fentanyl-Induced Respiratory Depression by Nalbuphine. Survey of Anesthesiology. 32(1). 23???24–23???24. 1 indexed citations
15.
Zsigmond, Elemér K., et al.. (1988). Nalbuphine as an Analgesic Component in Balanced Anesthesia for Cardiac Surgery. Survey of Anesthesiology. 32(3). 158–158. 12 indexed citations
16.
Zsigmond, Elemér K., et al.. (1987). Endocrine and Hemodynamic Effects of Antagonism of Fentanyl-Induced Respiratory Depression by Nalbuphine. Anesthesia & Analgesia. 66(5). 421–426. 10 indexed citations
17.
Zsigmond, Elemér K., et al.. (1987). Nalbuphine as an Analgesic Component in Balanced Anesthesia for Cardiac Surgery. Anesthesia & Analgesia. 66(11). 1155???1164–1155???1164. 8 indexed citations
18.
Barabás, Éva, et al.. (1986). Calcitonin secretion in rats with inflammation mediated osteopenia.. PubMed. 24(3). 167–9. 1 indexed citations
19.
Barabás, Éva, T. Kirkpatrick, & Elemér K. Zsigmond. (1984). INHIBITORY EFFECT OF ESMOLOL ON HUMAN PLASMA CHOLINESTERASE IN VITRO. Anesthesiology. 61(3). A308–A308. 4 indexed citations
20.
Barabás, Éva, et al.. (1978). 45Ca uptake in tooth germs: effects of parathormone, calcitonin and propranolol.. PubMed. 16(3). 213–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Faint Breakdown of academic impact, for papers by J.R. Bertino Breakdown of academic impact, for papers by James Lawrence Breakdown of academic impact, for papers by Edward D. Gilby Breakdown of academic impact, for papers by Nahed K. Ahmed Breakdown of academic impact, for papers by Larry W. Brox Breakdown of academic impact, for papers by E. Cama Breakdown of academic impact, for papers by Nancy S. Nicholson Breakdown of academic impact, for papers by Yuichiro Yabe Breakdown of academic impact, for papers by A C Cox
Rankless by CCL
2026